Denis Migliorini
Tracked across 1 events · 6 articles · First seen Sep 02, 2026 · Last active Sep 10, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
Researchers from University of Geneva and Geneva University Hospitals reported in Tata Communications that administering CAR-T cell immunotherapy before, rather than after, surgery for glioblastoma achieves markedly better and more durable tumor control. Glioblastoma survival…
Impact: Migliorini led the research and is the public face of the planned phase 1 trial, raising his profile in neuro-oncology and cell therapy.
Sep 02, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Denis Migliorini live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard